Nuclear Medicine Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Nuclear Medicine Therapeutics Market is Segmented by Type (Alpha Emitters, Beta Emitters, and Brachytherapy), Application (Oncology, Cardiology, Thyroid, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Nuclear Medicine Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Nuclear Medicine Therapeutics Industry Overview

The nuclear medicine therapeutics market is primarily dominated by a few key players operating globally and regionally. These companies are well-known and hold significant market shares. The competitive landscape of the market includes an analysis of both international and local companies.

Some of the major players in the nuclear medicine therapeutics market include Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Fusion Pharmaceuticals, IBA Radiopharma Solutions, RadioMedix Inc., Telix Pharmaceuticals Ltd, NTP Radioisotopes, Bracco SpA, Cardinal Health Inc., Nordion Inc. (Sotera Health Company), and Triad Isotopes (Jubilant Life Sciences).

Nuclear Medicine Therapeutics Market Leaders

  1. IBA Radiopharma Solutions

  2. Bayer AG

  3. Alpha Tau Medical Ltd

  4. Actinium Pharmaceutical Inc.

  5. Jubilant Life Sciences Company

  6. *Disclaimer: Major Players sorted in no particular order
Nuclear Medicine Therapeutics Market Concentration

Nuclear Medicine Therapeutics Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?